Droga pharma research and development
The research and development departments of Droga pharma was established in 2021 G.C with the aim of providing a state of the art research facility. The unit is currently focused on development and research on two wings: Pharmaceuticals and Nutraceuticals /Food supplements. The unit has experienced professionals providing services and conducting research and development both for the company and for pharmaceutical companies all over the globe.
DROGA RESEARCH GRANT
Formulation Department develops the drug products through formulation studies to maximize the effectiveness and safety of API, such as improving the solubility and stability, and controlling of drug release. The department is responsible for establishing the quality of the drug products as a continuum, from development through clinical manufacturing to commercial manufacturing.
The activities under this include, but not limited to the following:
- Formulations of pharmaceuticals
- Formulation of herbal medicines
- Formulations of nutraceuticals
The unit develops
- Solid Oral dosage forms
- Oral liquid dosage forms
- Semi solids &
- Injectable
The Research laboratory of Droga Pharma works on screening, identifying and developing Active Pharmaceutical ingredients so as to market, further develop into products and/or asses additional functions of the APIs and Raw materials with its fully equipped laboratories, Droga R&D will be engaged in the following activities:
- Screening of selected medicinal plants for activities
- Discovery of new compounds or APIs
- Conducting pre-formulation studies
- Conducting clinical trials for promising formulations of products
- Excipient discovery and development researches
Various QC tests are conducted for products obtained from different centers, industries, academic and other research institutes and regulatory bodies. within its physicochemical and microbiological laboratories, Droga R&D department will be engaged in:
- Establishment of the analytical procedures and specifications for API and drug products.
- Preparation of stability protocols
- Pursues analytical tests and stability studies of API and drug products
- In-house analytical method development laboratory with stability chambers
- Standardization of traditional medicines
- Provision of pharmacovigilance services
The department is involved in doing lead optimizations, preclinical evaluation safety/tolerability testing and post market surveillances. Basically, Conducting bioequivalence (BE) studies of generic products for both local pharmaceutical manufacturers and regional ones.
The activities under this include the following:
- Establishment of the laboratory for bioequivalence studies of generic products
- Establishment of a clinical center with 16 bed capacity
- Preparation of BE study protocol
The following calibration services will be offered by the center:
- Pharmaceutical equipment
- Medical diagnostic equipment
- Laboratory testing equipment
Consultations regarding the risk assessment of pharmaceutical manufacturing by mainly focusing on formulation potentials, developments and risks present on different dosage forms are done.
- Formulation and Manufacturing Processes Consulting
- Analytical method development & method validation
- Scale-Up/Technical Transfer Assistance
- Formulation Optimization/Rationalization
- Packaging development support
- Establishing strategic collaborations with potential partners (research and academic institutions, pharmaceutical and food industries, and regulatory bodies)
Droga Pharma provides research grants and trainings for young and senior researchers from academic and research institutions and organizes scientific conferences.
Scientific conferences and trainings
- Organizing annual scientific conference
- Organizing problem solving training for pharmaceutical industries
- Organizing and providing training regarding BE studies for interested bodies (academic and industries).
Grants/ Awards
- Provide research grant for young and senior researchers from academic and research institutions
Droga Pharma PLC is pleased to announce the first round of DRG award winners for the year 2022. The company’s grant award was launched in spring of 2022 to encourage & support junior & senior researchers that focus & are engaged in, health related problem solving, researches. For the year 2022 grants were to be awarded to research proposals that were within the thematic areas of, Excipient Development & Modification, Pharmaceutical Formulation Development, Nutraceutical Formulation Development, Food Supplements Formulation Development & Herbal Medicines. We are therefore happy to announce that Droga Research Grant 2022 has been awarded to two winning research proposals.
Congratulations to winners!
Next Grant Cycle starts in January 2023.